BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15035057)

  • 1. [Bone marrow fibrosis during therapy of hairy cell leukemia].
    Dĕdic K; Zák P
    Cesk Patol; 2004 Jan; 40(1):22-4. PubMed ID: 15035057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 2-chlorodeoxyadenosine therapy on bone marrow fibrosis in hairy cell leukemia.
    Dedic K; Zák P
    Neoplasma; 2004; 51(1):56-8. PubMed ID: 15004661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bone marrow changes in patients with hairy cell leukemia after 2-chlorodeoxyadenosine treatment].
    Urasiński I; Zdziarska B; Krygier-Stojałowska A
    Acta Haematol Pol; 1996; 27(1):49-55. PubMed ID: 8629443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Successful induction and complete improvement of myelofibrosis and erythema nosodum with cladribine in a case of hairy cell leukemia].
    Araki H; Matsunaga T; Murase K; Kuroda H; Kuribayashi K; Terui T; Niitsu Y
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):965-9. PubMed ID: 15222122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter retrospective analysis regarding the clinical manifestations and treatment results in patients with hairy cell leukemia: twenty-four year Turkish experience in cladribine therapy.
    Hacioglu S; Bilen Y; Eser A; Sivgin S; Gurkan E; Yildirim R; Aydogdu I; Dogu MH; Yilmaz M; Kayikci O; Tombak A; Kuku I; Celebi H; Akay MO; Esen R; Korkmaz S; Keskin A
    Hematol Oncol; 2015 Dec; 33(4):192-8. PubMed ID: 25393847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
    Konwalinka G; Schirmer M; Hilbe W; Fend F; Geisen F; Knoblechner A; Petzer A; Thaler J
    Blood Cells Mol Dis; 1995; 21(2):142-51. PubMed ID: 8846043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hairy cell leukemia, Japanese variant, successfully treated with cladribine].
    Miyazaki M; Taguchi A; Sakuragi S; Mitani N; Matsuda K; Shinohara K
    Rinsho Ketsueki; 2004 May; 45(5):405-7. PubMed ID: 15199752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptococcal meningitis occurring at 19 months after cladribine therapy for hairy cell leukemia.
    Ikpeazu EV; Kaplon MK
    Eur J Haematol; 1998 Oct; 61(4):286-7. PubMed ID: 9820640
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of alpha-interferon therapy on bone marrow fibrosis in hairy cell leukemia.
    Laughlin M; Islam A; Barcos M; Meade P; Ozer H; Gavigan M; Henderson E; Han T
    Blood; 1988 Sep; 72(3):936-9. PubMed ID: 3416078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary acute myeloid leukemia following successful treatment of hairy cell leukemia with cladribine.
    Seshadri P
    Leuk Res; 2000 Jul; 24(7):637. PubMed ID: 10979762
    [No Abstract]   [Full Text] [Related]  

  • 11. Lack of toxicity in a cladribine extravasation.
    Mateu-de Antonio J; Acuña-Reina L; Pons JC; Buisán MJ
    Ann Pharmacother; 1999; 33(7-8):873. PubMed ID: 10466922
    [No Abstract]   [Full Text] [Related]  

  • 12. Hairy cell leukemia (HCL) with extensive myelofibrosis responds to thalidomide.
    Strupp C; Fenk R; Kündgen A; Gattermann N; Haas R; Germing U
    Leuk Res; 2005 Aug; 29(8):967-9. PubMed ID: 15978949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
    Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K
    Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monitoring minimal residual disease in patients with hairy cell leukemia in complete remission after treatment with 2-chlorodioxyadenosine].
    Zák P; Chrobák L; Dĕdic K; Podzimek K
    Vnitr Lek; 2000 Oct; 46(10):697-703. PubMed ID: 11344629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia.
    Yang MH; Ho CH
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):54-8. PubMed ID: 11310372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cladribine in the treatment of hairy cell leukemia: initial and subsequent results.
    Huynh E; Sigal D; Saven A
    Leuk Lymphoma; 2009 Oct; 50 Suppl 1():12-7. PubMed ID: 19814692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-chlorodeoxyadenosine-associated transient acantholytic dermatosis in hairy cell leukemia patients.
    Cohen PR; Kurzrock R
    Am J Dermatopathol; 1999 Feb; 21(1):106-8. PubMed ID: 10027536
    [No Abstract]   [Full Text] [Related]  

  • 18. [Successful use of cladribine in the treatment of an elderly woman with typical hairy cell leukemia].
    Terasaki Y; Okumura H; Hirose A; Ishiura Y; Yokawa S; Saito K; Nakao S
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1885-8. PubMed ID: 18030031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary T-lymphoblastic leukemia in a patient with hairy cell leukemia following cladribine therapy: report of an extremely rare case and review of the literature.
    Setoodeh R; Zhang L
    Leuk Lymphoma; 2012 Apr; 53(4):736-8. PubMed ID: 21980957
    [No Abstract]   [Full Text] [Related]  

  • 20. The development of congestive cardiac failure in a patient with hairy cell leukemia treated with 2-chlorodeoxyadenosine.
    Koczwara B; Spangenthal E; Bernstein SH
    Leuk Lymphoma; 1997 Jul; 26(3-4):413-5. PubMed ID: 9322907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.